216 related articles for article (PubMed ID: 9735159)
1. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
Hamad I; Hunter AC; Szebeni J; Moghimi SM
Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
[TBL] [Abstract][Full Text] [Related]
3. α, ω-Cholesterol-functionalized low molecular weight polyethylene glycol as a novel modifier of cationic liposomes for gene delivery.
Ma CC; He ZY; Xia S; Ren K; Hui LW; Qin HX; Tang MH; Zeng J; Song XR
Int J Mol Sci; 2014 Nov; 15(11):20339-54. PubMed ID: 25383677
[TBL] [Abstract][Full Text] [Related]
4. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
5. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.
Holland JW; Hui C; Cullis PR; Madden TD
Biochemistry; 1996 Feb; 35(8):2618-24. PubMed ID: 8611565
[TBL] [Abstract][Full Text] [Related]
7. The interaction of liposomes with the complement system.
Szebeni J
Crit Rev Ther Drug Carrier Syst; 1998; 15(1):57-88. PubMed ID: 9523086
[TBL] [Abstract][Full Text] [Related]
8. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.
Awasthi VD; Garcia D; Klipper R; Goins BA; Phillips WT
J Pharmacol Exp Ther; 2004 Apr; 309(1):241-8. PubMed ID: 14718581
[TBL] [Abstract][Full Text] [Related]
9. Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.
Vertut-Doï A; Ishiwata H; Miyajima K
Biochim Biophys Acta; 1996 Jan; 1278(1):19-28. PubMed ID: 8611602
[TBL] [Abstract][Full Text] [Related]
10. Antibody-independent activation of C1, the first component of complement, by cardiolipin.
Kovacsovics T; Tschopp J; Kress A; Isliker H
J Immunol; 1985 Oct; 135(4):2695-700. PubMed ID: 4031497
[TBL] [Abstract][Full Text] [Related]
11. Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
Sroda K; Rydlewski J; Langner M; Kozubek A; Grzybek M; Sikorski AF
Cell Mol Biol Lett; 2005; 10(1):37-47. PubMed ID: 15809678
[TBL] [Abstract][Full Text] [Related]
12. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
Li W; Huang Z; MacKay JA; Grube S; Szoka FC
J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
[TBL] [Abstract][Full Text] [Related]
13. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
Chonn A; Cullis PR; Devine DV
J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.
Zalipsky S; Mullah N; Harding JA; Gittelman J; Guo L; DeFrees SA
Bioconjug Chem; 1997; 8(2):111-8. PubMed ID: 9095350
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
Moghimi SM; Hamad I; Andresen TL; Jørgensen K; Szebeni J
FASEB J; 2006 Dec; 20(14):2591-3. PubMed ID: 17065229
[TBL] [Abstract][Full Text] [Related]
16. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
[TBL] [Abstract][Full Text] [Related]
17. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
[TBL] [Abstract][Full Text] [Related]
18. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
[TBL] [Abstract][Full Text] [Related]
19. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
Park YS; Huang L
J Drug Target; 1993; 1(4):325-30. PubMed ID: 8069575
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
